Clinical Trials Browser

Blood Specimen Collection × Myeloid × 90 days × Clear all

Pyruvate Kinase Deficiency of Red Cells, Anemia, Hemolytic, Congenital, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT04953312 2026-03-12

CALPRO

Phase NA Withdrawn

MyeloidOther hematologic neoplasm

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT06510868 2026-03-05

MDS & PRRT

Recruiting

45 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06480591 2026-02-25

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Recruiting

35 enrolled

Myeloid

Myeloproliferative Disorders, Thrombosis

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

Enrolling by invitation

5,000 enrolled

LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Phase 1/2 Active not recruiting

43 enrolled

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Clinical Trials

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

CALPRO

MDS & PRRT

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Pathogenesis of Hematologic Malignancies

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation